Efficacy and Safety of TELMINUVO to Stage 2 Hypertension
Status:
Unknown status
Trial end date:
2014-08-01
Target enrollment:
Participant gender:
Summary
The aim of present study is to evaluate the efficacy and safety of two dose combination of
Telmisartan/S-Amlodipine (80/2.5mg and 80/5mg) compared with S-Amlodipine monotherapy (2.5mg
and 5mg) in patients with Stage 2 hypertension.